Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Pops Richard F
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   1,303,786    

Indirect Shares

   0      
Direct Value   $39,456,175    

Indirect Value

   $0      
Total Shares   1,303,786      
Total Value   $39,456,175      


Neurocrine Biosciences Inc $4,255,473 Alkermes Plc $29,303,127 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375 Neurocrine Biosciences Inc $4,255,473 Alkermes Plc $29,303,127 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX Director 2024-05-17 31,611 2005-11-23 0    Premium*  
            Alkermes Plc ALKS Director and CEO, Alke... 2024-02-08 1,179,675 2011-09-16 0    Premium*  
            Epizyme, Inc. EPZM Director 2013-05-30 60,000 0    Premium*  
            Acceleron Pharma Inc XLRN Director 2019-01-25 32,500 0    Premium*  
* Premium Members only  

Records found :    259         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 10 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2014-12-11 4 AS $56.14 $2,810,050 D/D (50,000) 520,063 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-11-29 4 AS $56.93 $1,709,469 D/D (30,000) 608,962 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2017-05-10 4 AS $57.12 $1,432,244 D/D (25,000) 630,406 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2017-05-17 4 AS $57.23 $2,909,439 D/D (50,000) 630,406 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2018-03-01 4 D $57.41 $446,592 D/D (7,779) 659,131 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2017-05-24 4 AS $57.42 $1,435,535 D/D (25,000) 630,406 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2017-05-28 4 D $57.70 $373,319 D/D (6,470) 637,686 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-11-22 4 AS $58.43 $1,759,936 D/D (30,000) 608,962 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2016-11-15 4 AS $58.78 $1,764,525 D/D (30,000) 608,962 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2017-03-01 4 D $59.71 $491,652 D/D (8,234) 623,523 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2015-10-05 4 D $59.77 $563,033 D/D (9,420) 553,497 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2015-05-28 4 D $59.92 $388,102 D/D (6,477) 542,917 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2018-03-03 4 D $60.05 $347,029 D/D (5,779) 666,352 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2017-03-03 4 D $60.97 $372,953 D/D (6,117) 630,406 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2005-11-23 4 S $61.55 $1,242,011 D/D (20,000) 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2015-05-21 4 D $61.80 $236,509 D/D (3,827) 535,644 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2015-05-20 4 D $62.10 $237,657 D/D (3,827) 531,346 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2015-09-10 4 AS $67.20 $3,378,387 D/D (50,000) 542,917 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2018-02-17 4 D $67.26 $173,598 D/D (2,581) 643,855 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2015-09-17 4 AS $70.88 $3,563,261 D/D (50,000) 542,917 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2015-12-07 4 AS $71.87 $2,702,433 D/D (37,500) 553,497 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2015-12-01 4 AS $71.99 $3,614,344 D/D (50,000) 553,497 0 -
ALKS Alkermes Plc Director and CEO, Alkermes plc   •       •      –    2015-03-03 4 D $72.80 $445,754 D/D (6,123) 526,940 0 -
NBIX Neurocrine Biosciences In... Director   –       •      –    2022-05-09 4 AS $76.29 $1,144,463 D/D (15,000) 29,512 0 %
NBIX Neurocrine Biosciences In... Director   –       •      –    2018-05-01 4 D $84.39 $105,741 D/D (1,253) 43,259 0 -
  259  Records found
  1   2   3   4   5   6   7   8   9   10  11      
  Page 10 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us